Lord Abbett Health Care Fund Class R5 (LHCTX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
18.53
+0.04 (0.22%)
Jul 3, 2025, 4:00 PM EDT
-6.51% (1Y)
Fund Assets | 3.27M |
Expense Ratio | 0.78% |
Min. Investment | $0.00 |
Turnover | n/a |
Dividend (ttm) | 0.11 |
Dividend Yield | 0.59% |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | Nov 26, 2024 |
Previous Close | 18.49 |
YTD Return | -4.19% |
1-Year Return | -6.01% |
5-Year Return | 26.68% |
52-Week Low | 16.71 |
52-Week High | 21.07 |
Beta (5Y) | n/a |
Holdings | 58 |
Inception Date | Jul 31, 2019 |
About LHCTX
The Fund's investment strategy focuses on Health/Biotech with 0.78% total expense ratio. Lord Abbett Securities Trust: Lord Abbett Health Care Fund; Class R5 Shares seeks long-term capital appreciation. Under normal market conditions, LHCTX will invest at least 80% of its assets in equity and equity-related securities of health care-related companies. LHCTX may invest in the securities of issuers of different countries throughout the world, including the United States.
Category Health
Stock Exchange NASDAQ
Ticker Symbol LHCTX
Share Class Class R5
Index MSCI ACWI/Health Care NR Index
Performance
LHCTX had a total return of -6.01% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.20%.
Top 10 Holdings
44.38% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 11.69% |
Boston Scientific Corporation | BSX | 4.91% |
Intuitive Surgical, Inc. | ISRG | 4.88% |
Stryker Corporation | SYK | 3.68% |
Gilead Sciences, Inc. | GILD | 3.67% |
argenx SE | ARGX | 3.43% |
Natera, Inc. | NTRA | 3.20% |
Tarsus Pharmaceuticals, Inc. | TARS | 3.19% |
Abbott Laboratories | ABT | 2.86% |
AstraZeneca PLC | AZN | 2.84% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Nov 26, 2024 | $0.1101 | Nov 26, 2024 |
Nov 22, 2022 | $0.0233 | Nov 22, 2022 |
Nov 23, 2021 | $1.4724 | Nov 23, 2021 |
Nov 24, 2020 | $2.3182 | Nov 24, 2020 |
Nov 21, 2019 | $0.0069 | Nov 21, 2019 |